# Kyoto University Innovation Capital

> Kyoto University Innovation Capital is a VC fund backing Health Care. See 110 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Kyoto, Japan
- Total investments: 110
- Last investment: Jul 2026
- Lead investor: 25%
- Fund size: $2.5B
- Last fund: Jan 2021
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/%E4%BA%AC%E9%83%BD%E5%A4%A7%E5%AD%A6%E3%82%A4%E3%83%8E%E3%83%99%E3%83%BC%E3%82%B7%E3%83%A7%E3%83%B3%E3%82%AD%E3%83%A3%E3%83%94%E3%82%BF%E3%83%AB%E6%A0%AA%E5%BC%8F%E4%BC%9A%E7%A4%BE/
- X (Twitter): https://twitter.com/kyoto_icap
- Website: http://www.kyoto-unicap.co.jp/
- Facebook: https://www.facebook.com/KYOTOiCAP/

Kyoto University Innovation Capital is a VC fund in Kyoto focused on Health Care and Biotechnology. Kyoto University Innovation Capital Co., Ltd. (Kyoto iCAP) was established in December 2014 with a 100% investment by Kyoto University . The Company provides investment and other support to companies that aim to commercialize "knowledge" (including research results and technologies) by researchers belonging to Kyoto University .

## Contacts

5 contacts available for Kyoto University Innovation Capital. Shizune tracks 2 team members at Kyoto University Innovation Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/kyoto-university-innovation-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 18 | 16% |
| Biotechnology | 17 | 15% |
| Medical | 16 | 15% |
| Manufacturing | 15 | 14% |
| Pharmaceutical | 12 | 11% |

82 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 28 | 25% |
| Series A | 21 | 19% |
| Series B | 17 | 15% |
| Funding Round | 16 | 15% |
| Venture - Series Unknown | 8 | 7% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Japan | 63 | 57% |
| United States | 3 | 3% |
| Taiwan | 1 | 1% |
| Austria | 1 | 1% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Hiroyuki Ueno | Principal | 2 | — |
| Ko Kusumi | President & CEO | 4 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Starlight Engine | Starlight Engine develops and commercializes fusion energy power plant technologies. | $37.4M | Seed | Jul 15, 2026 |  |
| Advance Composite | Advance Composite is a manufacturing company that develops composite materials and molten metal forging-based products. | $1.2M | Series B | Jul 02, 2026 |  |
| JiMED | JiMED designs & develops AI based brain-computer interface for implant in ALS patients to improve communication. | $2M |  | Jun 18, 2026 |  |
| xCARE | xCARE specializes in the development and commercialization phases of the pharmaceutical and medical device industries. | $3.7M | Series A | Jun 08, 2026 |  |
| YStory | YStory is a digital health firm that uses AI and medical science to improve women's health during menopause. |  | Seed | Apr 27, 2026 |  |
| Restore Vision | Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa. Restore Vision develops eye disease therapeutic agents. | $8.2M | Series B | Apr 15, 2026 |  |
| LOOPARTS | LOOPARTS focuses on high-purity metal resource recycling through molten salt electrolysis technology. |  | Seed | Jan 30, 2026 |  |
| LOOPARTS | LOOPARTS focuses on high-purity metal resource recycling through molten salt electrolysis technology. |  | Seed | Jan 30, 2026 |  |
| La Terra | La Terra is an agriculture technology company that develops artificial soil for indoor plantation and horticultural therapy​. | $316.7K | Venture - Series Unknown | Jan 19, 2026 |  |
| Physiologas Technologies | Physiologas Technologies is a manufacturing company that designs and develops medical equipment for the healthcare industry. |  | Series A | Dec 26, 2025 |  |

10 of 110 investments shown.

## Co-investors
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund, 19 deals together
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund, 19 deals together
- [Miraidoa](https://shizune.co/investors/profile/future-venture-capital) — VC Fund, 12 deals together
- [JAFCO](https://shizune.co/investors/profile/jafco-co-ltd) — VC Fund, 9 deals together
- [Energy & Environment Investment](https://shizune.co/investors/profile/energy-environment-investment) — VC Fund, 7 deals together
- [Keio Innovation Initiative](https://shizune.co/investors/profile/keio-innovations-initiative) — VC Fund, 7 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Kyoto University Innovation Capital invest in?

Kyoto University Innovation Capital invests primarily in Health Care, Biotechnology and Medical startups, most often at Seed and Series A stage. Most of the 110 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Kyoto University Innovation Capital?

Public channels for Kyoto University Innovation Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Kyoto University Innovation Capital?

The team at Kyoto University Innovation Capital includes Hiroyuki Ueno (Principal) and Ko Kusumi (President & CEO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co